Posted by Two Blokes
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical com
Source: Two Blokes Trading
Posted by Two Blokes
NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds p
Source: Two Blokes Trading
Posted by Two Blokes
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST tria
Source: Two Blokes Trading
Posted by Two Blokes
Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than
Source: Two Blokes Trading
Posted by Two Blokes
Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than
Source: Two Blokes Trading
Posted by Two Blokes
First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu
Source: Two Blokes Trading
Posted by Two Blokes
First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tu
Source: Two Blokes Trading
Posted by Two Blokes
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted
Source: Two Blokes Trading
Posted by Two Blokes
PayPal stock price on Tuesday, when it publishes its first-quarter financial results, will show whether its bu
Source: Two Blokes Trading
Posted by Two Blokes
It's been a wild start to the year for Lucid Group (LCID 1.84%) investors. Founder and former CEO Peter Rawlin
Source: Two Blokes Trading
Posted by Two Blokes
I'm not going to sugarcoat this: Machine vision company Cognex (CGNX 0.27%) is heading for a tough year, and t
Source: Two Blokes Trading
Posted by Two Blokes
Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than
Source: Two Blokes Trading